NYSE:UHS - Universal Health Services Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $148.44
  • Forecasted Upside: -0.65 %
  • Number of Analysts: 8
  • Breakdown:
  • 2 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$149.42
▼ -0.29 (-0.19%)

This chart shows the closing price for UHS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Universal Health Services Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UHS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UHS

Analyst Price Target is $148.44
▼ -0.65% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Universal Health Services in the last 3 months. The average price target is $148.44, with a high forecast of $168.00 and a low forecast of $115.00. The average price target represents a -0.65% upside from the last price of $149.42.

This chart shows the closing price for UHS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 contributing investment analysts is to hold stock in Universal Health Services. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 2 sell ratings
1/1/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 2 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 2 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 2 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 2 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 2 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 2 sell ratings
6/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/10/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$160.00 ➝ $165.00Low
5/5/2021MizuhoBoost Price TargetBuy$151.00 ➝ $168.00Low
4/28/2021Royal Bank of CanadaBoost Price TargetOutperform$150.00 ➝ $160.00Medium
4/19/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$145.00 ➝ $160.00Low
3/14/2021JPMorgan Chase & Co.Reiterated RatingSell$115.00Medium
3/2/2021CitigroupLower Price Target$162.00 ➝ $151.00Low
1/5/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$135.00 ➝ $145.00N/A
1/5/2021Bank of AmericaDowngradeNeutral ➝ Underperform$144.00N/A
12/18/2020MizuhoBoost Price TargetBuy$130.00 ➝ $151.00High
12/15/2020The Goldman Sachs GroupInitiated CoverageNeutral$149.00Medium
11/11/2020Piper SandlerBoost Price TargetNeutral$117.00 ➝ $139.00Medium
11/2/2020Credit Suisse GroupBoost Price TargetOutperform$140.00 ➝ $145.00Medium
9/21/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$138.00 ➝ $115.00High
7/30/2020Royal Bank of CanadaReiterated RatingBuyLow
7/29/2020Piper SandlerBoost Price TargetNeutral$113.00 ➝ $117.00Medium
7/29/2020Credit Suisse GroupBoost Price TargetOutperform$139.00 ➝ $140.00Medium
6/9/2020BarclaysUpgradeEqual Weight ➝ Overweight$138.00High
5/29/2020MizuhoLower Price TargetBuy$136.00 ➝ $130.00Medium
4/30/2020Royal Bank of CanadaReiterated RatingBuyHigh
4/30/2020UBS GroupLower Price TargetBuy$150.00 ➝ $133.00High
4/29/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$165.00 ➝ $135.00High
4/28/2020CitigroupLower Price TargetBuy$157.00 ➝ $128.00High
4/23/2020Piper SandlerLower Price TargetNeutral$141.00 ➝ $113.00High
3/23/2020Bank of AmericaDowngradeBuy ➝ Neutral$182.00 ➝ $104.00High
3/2/2020JPMorgan Chase & Co.Lower Price TargetNeutral$164.00 ➝ $155.00High
2/28/2020Robert W. BairdBoost Price TargetOutperform$160.00 ➝ $165.00High
2/28/2020UBS GroupLower Price TargetBuy$158.00 ➝ $150.00High
2/28/2020StephensLower Price TargetEqual Weight$153.00 ➝ $151.00High
2/28/2020BarclaysReiterated RatingHold$145.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$140.00Low
12/20/2019JPMorgan Chase & Co.Boost Price TargetNeutral$159.00 ➝ $164.00Medium
7/31/2019Morgan StanleyBoost Price TargetEqual Weight$135.00 ➝ $146.00Low
7/30/2019Royal Bank of CanadaBoost Price TargetOutperform$165.00Low
7/29/2019Credit Suisse GroupBoost Price TargetOutperform$150.00 ➝ $170.00Low
7/26/2019BarclaysSet Price TargetHold$145.00N/A
7/26/2019Bank of AmericaBoost Price TargetBuy ➝ Buy$158.00 ➝ $165.00Low
6/7/2019UBS GroupReiterated RatingBuy$151.00Medium
4/29/2019BMO Capital MarketsLower Price TargetMarket Perform$138.00Medium
4/17/2019BarclaysLower Price TargetEqual Weight ➝ Equal Weight$136.00 ➝ $130.00Medium
3/5/2019BMO Capital MarketsBoost Price TargetMarket Perform$146.00Low
3/4/2019UBS GroupBoost Price TargetBuy ➝ Buy$156.00 ➝ $161.00Low
3/4/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$147.00High
3/1/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$140.00 ➝ $160.00Low
3/1/2019BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$130.00 ➝ $136.00Low
3/1/2019Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$147.00 ➝ $150.00Low
3/1/2019CitigroupBoost Price TargetBuy ➝ Buy$140.00 ➝ $164.00Low
2/28/2019MizuhoSet Price TargetIn-Line ➝ Buy$150.00Medium
2/28/2019Robert W. BairdBoost Price TargetOutperform ➝ Outperform$140.00 ➝ $145.00Medium
1/14/2019StephensInitiated CoverageEqual ➝ Equal Weight$134.00Medium
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$140.00Medium
12/13/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell$125.00High
11/15/2018UBS GroupInitiated CoverageBuy ➝ Buy$156.00High
10/29/2018SVB LeerinkLower Price TargetOutperform$140.00 ➝ $135.00Medium
10/29/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$134.00 ➝ $130.00Medium
10/29/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$135.00 ➝ $130.00Medium
10/29/2018CitigroupLower Price TargetBuy ➝ Buy$145.00 ➝ $140.00Low
9/18/2018Bank of AmericaUpgradeNeutral ➝ Buy$128.00 ➝ $155.00High
9/5/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$122.00 ➝ $134.00Low
8/14/2018BarclaysInitiated CoverageEqual Weight$135.00Low
8/1/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$130.00Low
7/27/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$120.00 ➝ $122.00Low
7/18/2018The Goldman Sachs GroupDowngradeBuy ➝ Neutral$120.00Medium
4/27/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$124.00 ➝ $120.00Low
3/6/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$132.00 ➝ $138.00Low
3/6/2018Robert W. BairdReiterated RatingBuy$122.00 ➝ $140.00Low
3/5/2018Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$135.00 ➝ $140.00Low
3/2/2018Royal Bank of CanadaReiterated RatingBuy$136.00High
3/2/2018Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$122.00 ➝ $124.00High
3/2/2018BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$125.00 ➝ $130.00High
3/1/2018StephensSet Price TargetHold$120.00High
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$144.00High
1/24/2018MizuhoSet Price TargetBuy$137.00Low
1/4/2018Royal Bank of CanadaReiterated RatingBuy$134.00Medium
1/3/2018The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$137.00High
1/3/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$147.00High
12/19/2017Credit Suisse GroupReiterated RatingOutperform$125.00 ➝ $135.00Low
12/12/2017CitigroupUpgradeNeutral ➝ BuyMedium
11/10/2017Credit Suisse GroupLower Price TargetOutperform$126.00 ➝ $125.00N/A
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$126.00N/A
10/27/2017Royal Bank of CanadaReiterated RatingBuy$126.00N/A
10/27/2017CitigroupLower Price TargetNeutral$126.00 ➝ $114.00N/A
10/27/2017Piper Jaffray CompaniesReiterated RatingBuy$117.00N/A
10/27/2017Robert W. BairdReiterated RatingBuy$122.00N/A
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$125.00N/A
10/11/2017StephensInitiated CoverageEqual ➝ Equal Weight$120.00N/A
10/3/2017Royal Bank of CanadaReiterated RatingBuy$147.00Low
9/22/2017SVB LeerinkBoost Price TargetOutperform$130.00 ➝ $132.00Low
9/7/2017KeyCorpReiterated RatingBuy$127.00Low
8/29/2017Royal Bank of CanadaReiterated RatingBuy$147.00High
8/17/2017Morgan StanleyLower Price TargetEqual Weight$120.00 ➝ $114.00Low
7/28/2017Piper Jaffray CompaniesReiterated RatingBuy$134.00Medium
7/26/2017CitigroupLower Price TargetNeutral$131.00 ➝ $126.00High
6/6/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$124.00Low
4/27/2017Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$157.00 ➝ $153.00Low
4/17/2017Piper Jaffray CompaniesReiterated RatingOverweight$147.00Low
4/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$145.00Low
3/27/2017MizuhoUpgradeNeutral ➝ Buy$133.00 ➝ $138.00High
3/6/2017Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$119.00 ➝ $147.00N/A
2/27/2017MizuhoBoost Price TargetNeutral ➝ Neutral$115.00 ➝ $133.00N/A
2/14/2017Wolfe ResearchUpgradeMarket Perform ➝ OutperformN/A
1/3/2017Piper Jaffray CompaniesInitiated CoverageNeutral$119.00N/A
12/14/2016Raymond JamesReiterated RatingOutperform ➝ Market PerformN/A
12/14/2016UBS GroupDowngradeOutperform ➝ Market PerformN/A
12/9/2016Credit Suisse GroupReiterated RatingNeutral$130.00N/A
12/9/2016MizuhoReiterated RatingBuy$133.00N/A
11/14/2016BarclaysReiterated RatingHold$147.00N/A
11/9/2016Avondale PartnersDowngradeOutperform ➝ Market PerformN/A
11/9/2016MizuhoDowngradeBuy ➝ Neutral$133.00N/A
11/9/2016Bank of AmericaDowngradeBuy ➝ Neutral$150.00 ➝ $135.00N/A
10/27/2016MizuhoLower Price TargetBuy$150.00 ➝ $142.00N/A
10/25/2016Wolfe ResearchInitiated CoverageMarket PerformN/A
8/30/2016Credit Suisse GroupReiterated RatingHold$130.00N/A
8/22/2016UBS GroupReiterated RatingBuyN/A
7/29/2016JPMorgan Chase & Co.Boost Price TargetOverweight$138.00 ➝ $150.00N/A
7/29/2016SVB LeerinkReiterated RatingBuy$150.00N/A
7/28/2016BarclaysLower Price TargetEqual Weight$150.00 ➝ $147.00N/A
6/29/2016Credit Suisse GroupReiterated RatingHold$140.00N/A
(Data available from 6/24/2016 forward)
Universal Health Services logo
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 25, 2021, it owned and/or operated 360 inpatient facilities, and 39 outpatient and other facilities located in 38 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Read More

Today's Range

Now: $149.42
Low: $148.52
High: $150.96

50 Day Range

MA: $154.15
Low: $141.12
High: $160.60

52 Week Range

Now: $149.42
Low: $86.67
High: $162.51

Volume

657,579 shs

Average Volume

621,911 shs

Market Capitalization

$12.73 billion

P/E Ratio

12.66

Dividend Yield

0.53%

Beta

1.21

Frequently Asked Questions

What sell-side analysts currently cover shares of Universal Health Services?

The following equities research analysts have issued research reports on Universal Health Services in the last twelve months: Bank of America Co., Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Mizuho, Piper Sandler, Royal Bank of Canada, The Goldman Sachs Group, Inc., TheStreet, and Zacks Investment Research.
View the latest analyst ratings for UHS.

What is the current price target for Universal Health Services?

9 Wall Street analysts have set twelve-month price targets for Universal Health Services in the last year. Their average twelve-month price target is $148.44, suggesting a possible downside of 0.8%. Mizuho has the highest price target set, predicting UHS will reach $168.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $115.00 for Universal Health Services in the next year.
View the latest price targets for UHS.

What is the current consensus analyst rating for Universal Health Services?

Universal Health Services currently has 2 sell ratings, 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in UHS, but not buy more shares or sell existing shares.
View the latest ratings for UHS.

What other companies compete with Universal Health Services?

How do I contact Universal Health Services' investor relations team?

Universal Health Services' physical mailing address is 367 S GULPH RD, KING OF PRUSSIA PA, 19406. The health services provider's listed phone number is (610) 768-3300 and its investor relations email address is [email protected] The official website for Universal Health Services is www.uhsinc.com.